Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancerHans von der Maase, Lisa Sengelov, James T Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogueCarlton K K Lee, Eric K Rowinsky, Jing Li, et al.
British Journal of Cancer|July 29, 2016
FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experienceMuralidharan K Chllamma, Natalie Cook, Neesha C Dhani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combinationCarol A Townsley, Gregory R Pond, Amit M Oza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2012
Phase II clinical and pharmacokinetic study of aflibercept in patients with previously treated metastatic colorectal cancerPatricia A Tang, Steven J Cohen, Christian Kollmannsberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trialJennifer J Knox, David Hedley, Amit Oza, et al.
The Oncologist|May 2, 2007
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumorsDirk Strumberg, Jeffrey W Clark, Ahmad Awada, et al.
Annals of Surgical Oncology|March 31, 2016
Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II TrialAlice C Wei, Natalie G Coburn, Katharine S Devitt, et al.
Urologic Oncology|May 24, 2005
A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancerEric Winquist, Malcolm J Moore, Kim N Chi, et al.
Cancer|September 9, 2010
Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3Gilda da Cunha Santos, Neesha Dhani, Dongsheng Tu, et al.
Pageof 10